Skip to content

Clinical trials

Completed Oppositional Defiant Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Oppositional Defiant Disorder Status: Completed Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20043
20051
20067
20071
20091
20101
20115
20122
20144
20154
20163
20176
20183
20192
20202
20211
20223
20244

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed59

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Karolinska Institutet4
Eli Lilly and Company3
Centre for Addiction and Mental Health2
Florida International University2
Indiana University2
Janssen Pharmaceutica N.V., Belgium2
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital2
Oregon Research Institute2
University Hospital, Montpellier2
University of California, San Francisco2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Oppositional Defiant Disorder59
Attention Deficit Disorder with Hyperactivity33
Conduct Disorder32
Attention Deficit and Disruptive Behavior Disorders13
Anxiety Disorders9
Mental Disorders6
Child Development Disorders, Pervasive3
Disruptive, Impulse Control, and Conduct Disorders3
Substance-Related Disorders3
Autistic Disorder2

Trials

Showing 76 to 59 of 59. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.